Dr. Stanley L. Liauw
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Studies Prostate Cancer
Studies Skin Cancer
5 reported clinical trials
18 drugs studied
Area of expertise
1Prostate Cancer
Stage I
Stage II
Stage IV
2Skin Cancer
Affiliated Hospitals
Clinical Trials Stanley L. Liauw is currently running
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
MRI-Guided Radiation
for Prostate Cancer
The purpose of this research is to gather information on the safety and effectiveness of using an imaging technique called magnetic resonance imaging (MRI) to decrease radiation dose to the uninvolved prostate (areas of the prostate that do not clearly have cancer cells) while increasing radiation dose to the nodules (hardened areas of the prostate that have cancer cells).
Recruiting1 award N/A
More about Stanley L. Liauw
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Stanley L. Liauw has experience with
- Bicalutamide
- MRI
- Dutasteride
- Finasteride
- Radiation
- ProstAtak® Immunotherapy
Breakdown of trials Stanley L. Liauw has run
Prostate Cancer
Skin Cancer
Renal Cell Carcinoma
Kidney Cancer
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stanley L. Liauw specialize in?
Stanley L. Liauw focuses on Prostate Cancer and Skin Cancer. In particular, much of their work with Prostate Cancer has involved Stage I patients, or patients who are Stage II.
Is Stanley L. Liauw currently recruiting for clinical trials?
Yes, Stanley L. Liauw is currently recruiting for 2 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Stanley L. Liauw has studied deeply?
Yes, Stanley L. Liauw has studied treatments such as Bicalutamide, MRI, Dutasteride.
What is the best way to schedule an appointment with Stanley L. Liauw?
Apply for one of the trials that Stanley L. Liauw is conducting.
What is the office address of Stanley L. Liauw?
The office of Stanley L. Liauw is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.